Dec 02, 2015 22:00 pm UTC| Business
TEANECK, N.J., Dec. 02, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address...
MarketAxess Announces Monthly Volume Statistics for November 2015
Dec 02, 2015 22:00 pm UTC| Business
NEW YORK, Dec. 02, 2015 (GLOBE NEWSWIRE) -- MarketAxess Holdings Inc. (Nasdaq:MKTX), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade...
Dec 02, 2015 21:55 pm UTC| Business
NEW YORK, Dec. 02, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi Korsinsky, LLP: You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the...
LPL Financial to Present at the Goldman Sachs US Financial Services Conference 2015
Dec 02, 2015 21:53 pm UTC| Business
BOSTON, Dec. 02, 2015 (GLOBE NEWSWIRE) -- Leading retail investment advisory firm and independent broker/dealer LPL Financial LLC, a wholly owned subsidiary of LPL Financial Holdings Inc. (NASDAQ:LPLA), today announced...
Marathon Oil Releases Solomon Exploration Well Results
Dec 02, 2015 21:30 pm UTC| Business
HOUSTON, Dec. 02, 2015 (GLOBE NEWSWIRE) -- Marathon Oil Corporation (NYSE: MRO) announced today the Solomon exploration well in the Gulf of Mexico reached its total depth of approximately 34,600 feet on Walker Ridge...
MacroGenics to Present at the Oppenheimer 26th Annual Healthcare Conference
Dec 02, 2015 21:30 pm UTC| Business
ROCKVILLE, Md., Dec. 02, 2015 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics...
Ultragenyx to Present at the Oppenheimer Annual Healthcare Conference
Dec 02, 2015 21:30 pm UTC| Business
NOVATO, Calif., Dec. 02, 2015 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced...